Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GOSS Gossamer Bio Inc.

盘前交易 07-01 04:22:36 EDT

0.9009

-0.0512

-5.38%

最高0.9636	最低0.8901	成交量130.99万
今开0.9439	昨收0.9521	日振幅7.72%
总市值2.04亿	流通市值1.71亿	总股本2.26亿
成交额120.73万	换手率0.69%	流通股本1.90亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GOSS","market":"US","secType":"STK","nameCN":"Gossamer Bio Inc.","latestPrice":0.9009,"timestamp":1719604800000,"preClose":0.9521,"halted":0,"volume":1309904,"delay":0,"floatShares":189871399,"shares":226218652,"eps":-0.935448,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0512,"latestTime":"07-01 04:22:36 EDT","open":0.9439,"high":0.9636,"low":0.8901,"amount":1207339.99699152,"amplitude":0.077198,"askPrice":1,"askSize":100,"bidPrice":0.764,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.935448,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1719840600000},"adr":0,"listingDate":1549602000000,"adjPreClose":0.9009,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.8901,"preClose":0.9009,"latestTime":"19:45 EDT","volume":14030,"amount":12646.0656,"timestamp":1719618315821},"volumeRatio":0.16976943698658226,"impliedVol":0.6174,"impliedVolPercentile":0.088},"requestUrl":"/m/hq/s/GOSS","defaultTab":"news","newsList":[{"id":"2446239605","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.00%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446239605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446239605?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:39","pubTimestamp":1719409185,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时39分，Gossamer Bio, Inc.股票出现异动，股价急速跳水5.00%。截至发稿，该股报0.960美元/股，成交量61.2444万股，换手率0.27%，振幅4.01%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213945941f166b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213945941f166b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2445207234","title":"Gossamer Bio, Inc.盘中异动 大幅拉升7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445207234","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445207234?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235889,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，Gossamer Bio, Inc.股票出现波动，股价急速上涨7.69%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。消息层面，截至21时31分，《Gossamer BioSmith Robert Paul JR增持2.5万股普通股股份，价值约1.51万美元》资讯为影响Gossamer Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213129941f08fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213129941f08fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2445750302","title":"Gossamer Bio, Inc.盘中异动 早盘快速拉升6.07%报0.603美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445750302","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445750302?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:31","pubTimestamp":1718976710,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时31分，Gossamer Bio, Inc.股票出现波动，股价大幅拉升6.07%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。消息层面，截至21时31分，《Gossamer BioSmith Robert Paul JR增持2.5万股普通股股份，价值约1.51万美元》资讯为影响Gossamer Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406212131509f56bdc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406212131509f56bdc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2444214688","title":"Gossamer Bio, Inc.盘中异动 快速上涨5.27%报0.571美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444214688","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444214688?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890262,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分，Gossamer Bio, Inc.股票出现波动，股价大幅上涨5.27%。截至发稿，该股报0.571美元/股，成交量1.1922万股，换手率0.01%，振幅3.50%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。消息层面，截至21时31分，《高盛集团维持Gossamer Bio买入评级，维持目标价8美元》资讯为影响Gossamer Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406202131029f52d5b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406202131029f52d5b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"2444913611","title":"BUZZ-在竞争对手 Aerovate 取消先导药物后期试验后，Gossamer Bio 公司业绩上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2444913611","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444913611?lang=zh_cn&edition=full","pubTime":"2024-06-17 23:51","pubTimestamp":1718639505,"startTime":"0","endTime":"0","summary":"    6月17日 - ** 在竞争对手Aerovate Therapeutics   取消了 。** Aerovate的唯一产品AV-101在一项中后期研究的中期部分未能达到关键目标，导致股价下跌超过92%，至1.89美元。** AV-101 在患有肺动脉高压 的成人中进行了测试，其特点是肺部动脉血压过高。** Gossamer 公司的实验性疗法 seralutinib 目前正处于 PAH 治疗的后期开发阶段。** 券商 Leerink Partners 表示，Aerovate 的更新没有对已经取得令人鼓舞的中期结果的 GOSS 进行疗效解读。** 随着 AVTE 项目的终止，GOSS 可能会有更多的 PAH 患者可以入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4539","AVTE","BK4505","BUZZ"],"gpt_icon":0},{"id":"2444603921","title":"Gossamer Bio, Inc.盘中异动 早盘急速拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444603921","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444603921?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631061,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分，Gossamer Bio, Inc.股票出现异动，股价急速上涨5.77%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Xtl生物制药涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Longeveron Inc.较为活跃，换手率分别为2089.86%、351.76%、56.36%，振幅较大的相关个股有Mustang Bio, Inc.、Sellas Life Sciences Group, Inc.、Lixte Biotechnology Holdings, Inc.，振幅分别为7.62%、4.00%、2.86%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213101aef5491d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213101aef5491d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2441091021","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.00%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441091021","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441091021?lang=zh_cn&edition=full","pubTime":"2024-06-08 01:35","pubTimestamp":1717781709,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日01时35分，Gossamer Bio, Inc.股票出现波动，股价大幅下跌5.00%。截至发稿，该股报0.570美元/股，成交量59.3362万股，换手率0.26%，振幅9.15%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608013509aef4159e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608013509aef4159e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2441257249","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441257249","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441257249?lang=zh_cn&edition=full","pubTime":"2024-06-05 03:59","pubTimestamp":1717531168,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日03时59分，Gossamer Bio, Inc.股票出现异动，股价大幅下挫5.01%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.65%。其相关个股中，Annexon, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Fresh2 Group Limited涨幅较大，Bio-Path Holdings, Inc.、Silo Pharma, Inc.、Annexon, Inc.较为活跃，换手率分别为101.79%、53.20%、51.34%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为181.00%、60.77%、59.76%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060503592896811ef5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060503592896811ef5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","ANNX","GOSS"],"gpt_icon":0},{"id":"2440349688","title":"Gossamer Bio, Inc.盘中异动 快速拉升5.08%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440349688","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440349688?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:54","pubTimestamp":1717422844,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时54分，Gossamer Bio, Inc.股票出现异动，股价快速拉升5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Cingulate Inc C/Wts 10/12/2026 、Bio-Path Holdings, Inc.涨幅较大，Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为2147.82%、62.16%、28.23%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为57.28%、27.03%、24.83%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603215404af8ba7cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603215404af8ba7cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2440945837","title":"Gossamer Bio, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440945837","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440945837?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:34","pubTimestamp":1717176862,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日01时34分，Gossamer Bio, Inc.股票出现波动，股价急速拉升5.03%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Scisparc Ltd.、Genprex, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为57.87%、48.55%、32.17%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为97.32%、61.42%、50.12%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601013423968112a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601013423968112a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2437942056","title":"Gossamer Bio, Inc.盘中异动 快速下跌5.62%报0.601美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437942056","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437942056?lang=zh_cn&edition=full","pubTime":"2024-05-24 22:37","pubTimestamp":1716561478,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日22时37分，Gossamer Bio, Inc.股票出现波动，股价大幅下挫5.62%。截至发稿，该股报0.601美元/股，成交量39.3031万股，换手率0.17%，振幅7.29%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524223758aef19741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524223758aef19741&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"2437290975","title":"Gossamer Bio, Inc.盘中异动 临近午盘股价大跌5.94%报0.630美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437290975","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437290975?lang=zh_cn&edition=full","pubTime":"2024-05-22 23:37","pubTimestamp":1716392227,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日23时37分，Gossamer Bio, Inc.股票出现异动，股价快速跳水5.94%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：重申Gossamer Bio评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522233707af89b16d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522233707af89b16d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2436104026","title":"HC Wainwright & Co.：重申Gossamer Bio(GOSS.US)评级，由买入调整至买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2436104026","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436104026?lang=zh_cn&edition=full","pubTime":"2024-05-20 23:15","pubTimestamp":1716218149,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Gossamer Bio(GOSS.US)评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405202315538b1c1d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405202315538b1c1d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS"],"gpt_icon":0},{"id":"2433790722","title":"Wedbush：重申Gossamer Bio(GOSS.US)评级，由优于大市调整至优于大市评级, 目标价4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433790722","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433790722?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:26","pubTimestamp":1715178418,"startTime":"0","endTime":"0","summary":"Wedbush：重申Gossamer Bio(GOSS.US)评级，由优于大市调整至优于大市评级, 目标价4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082227008ae8f9b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082227008ae8f9b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS"],"gpt_icon":0},{"id":"2433934721","title":"Gossamer Bio, Inc.盘中异动 急速上涨5.13%报0.769美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433934721","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433934721?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:30","pubTimestamp":1715175030,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时30分，Gossamer Bio, Inc.股票出现异动，股价急速拉升5.13%。截至发稿，该股报0.769美元/股，成交量4037股，换手率0.00%，振幅0.00%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Repare Therapeutics Inc.、Enveric Biosciences, Inc.、Corvus Pharmaceuticals, Inc.涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为196.73%、24.62%、9.62%，振幅较大的相关个股有Diamedica Therapeutics Inc.、Y-Mabs Therapeutics, Inc.、Nanoviricides, Inc.，振幅分别为5.16%、5.11%、4.76%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213031861ebc3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213031861ebc3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2433756216","title":"Gossamer Bio Inc 报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433756216","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433756216?lang=zh_cn&edition=full","pubTime":"2024-05-08 06:32","pubTimestamp":1715121170,"startTime":"0","endTime":"0","summary":"   * Gossamer Bio Inc   报告，截至3月底的季度调整后每股亏损19美分，高于去年同期的每股-52美分。华尔街预期为每股-25美分至-15美分。* Gossamer Bio Inc 公布的本季度每股收益为亏损 19 美分。* Gossamer Bio Inc 的股价本季度下跌了 33.8%，今年迄今为止下跌了 14.4%。5月7日 - 预测变化   * 在过去三个月中，分析师的平均盈利预期上升了约 2.5%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Gossamer Bio Inc 的 12 个月目标价中位数为 5.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":"    路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻  * 艾睿电子  ：雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc   ：杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc   ：贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc   ：奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc   ：Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IR","VERX","CTO","ATI","ACT","GOOD","BK4204","LINC","LU1064131342.USD","HIMS","PACS","BOWL","PLTR","ACA","BK4550","HWM","GOSS","IART","PNW","LMND","CAH","CRNX","GLYC","AIG","CIVI","BK4117","LYRA","FIS","ENTA","BK4567","NOW","MCHP","BCRX","BECN","FRPT","ARW","COTY","BV","LITE","BK4097","ACHC","EVER","DSGN","MTZ","VRTX","APA","KRC","LU0889566641.SGD","CTRA"],"gpt_icon":0},{"id":"2433285792","title":"Gossamer Bio, Inc.盘中异动 下午盘快速拉升5.39%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433285792","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433285792?lang=zh_cn&edition=full","pubTime":"2024-05-07 01:56","pubTimestamp":1715018169,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日01时56分，Gossamer Bio, Inc.股票出现异动，股价大幅拉升5.39%。截至发稿，该股报0.780美元/股，成交量632.456万股，换手率2.80%，振幅8.11%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050701561087e85e06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050701561087e85e06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2433518421","title":"Gossamer Bio 与 Chiesi 集团合作开发血压治疗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2433518421","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433518421?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:41","pubTimestamp":1714995716,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透5月6日 - Gossamer Bio   公司周一表示，它将与Chiesi集团合作开发和商业化其药物seralutinib，用于与血压有关的多种适应症。作为交易的一部分，Gossamer将获得1.6亿美元的开发补偿金，并有资格获得高达1.46亿美元的监管奖励和1.8亿美元的销售奖励。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2432975626","title":"Gossamer Bio Inc   预计每股亏损19美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432975626","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432975626?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:54","pubTimestamp":1714737262,"startTime":"0","endTime":"0","summary":"   * Gossamer Bio Inc    预计在5月7日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Gossamer Bio Inc 每股亏损 19 美分。* 在过去三个月中，分析师的平均盈利预期上升了约 0.1%。* 华尔街对 Gossamer Bio Inc 的 12 个月目标价中值为 4.00 美元，高于其上一次收盘价 0.77 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gossamerbio.com","stockEarnings":[{"period":"1week","weight":0.386},{"period":"1month","weight":0.5424},{"period":"3month","weight":-0.2365},{"period":"6month","weight":-0.0127},{"period":"1year","weight":-0.2555},{"period":"ytd","weight":-0.0127}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gossamer Bio, Inc.于2015年10月26日根据特拉华州法律以FSG, Bio, Inc.的名字注册成立，并于2017年更名为Gossamer Bio, Inc.,Gossamer Bio, Inc.是一家临床阶段的生物制药公司，专注于免疫,炎症和肿瘤学疾病领域的治疗方法的研究。他们的目标是成为这些治疗领域的行业领导者，并延长患有此类疾病的患者的寿命。为了实现这一目标，他们组建了一支来自世界各地的经验丰富，技术精湛的行业资深人士。这些专家们的免疫学知识是他们公司的基础。他们的企业文化是科学严谨和包容，努力为患者提供更好的治疗选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.024165},{"month":2,"riseRate":0.2,"avgChangeRate":0.038976},{"month":3,"riseRate":0,"avgChangeRate":-0.120634},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.096492},{"month":5,"riseRate":0.5,"avgChangeRate":-0.019482},{"month":6,"riseRate":0.666667,"avgChangeRate":0.141617},{"month":7,"riseRate":0.4,"avgChangeRate":0.04931},{"month":8,"riseRate":0.8,"avgChangeRate":0.099847},{"month":9,"riseRate":0.2,"avgChangeRate":-0.076401},{"month":10,"riseRate":0.2,"avgChangeRate":-0.118152},{"month":11,"riseRate":0.6,"avgChangeRate":0.102557},{"month":12,"riseRate":0.6,"avgChangeRate":-0.165945}],"exchange":"NASDAQ","name":"Gossamer Bio Inc.","nameEN":"Gossamer Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gossamer Bio Inc.,GOSS,Gossamer Bio Inc.股票,Gossamer Bio Inc.股票老虎,Gossamer Bio Inc.股票老虎国际,Gossamer Bio Inc.行情,Gossamer Bio Inc.股票行情,Gossamer Bio Inc.股价,Gossamer Bio Inc.股市,Gossamer Bio Inc.股票价格,Gossamer Bio Inc.股票交易,Gossamer Bio Inc.股票购买,Gossamer Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}